CNSX:MMEN

Medmen Enterprises Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume770,154 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive MMEN News and Ratings via Email

Sign-up to receive the latest news and ratings for Medmen Enterprises and its competitors with MarketBeat's FREE daily newsletter.

About Medmen Enterprises

MedMen Enterprises Inc., together with its subsidiaries, operates as a cannabis company in the United States. The company cultivates, produces, and distributes, and retails recreational and medicinal cannabis. As of November 1, 2018, it had licenses for 69 retail stores; and 17 cultivation and production facilities across 12 states. The company is headquartered in Culver City, California.

MedMen Announces Non-Brokered Private Placement to Drive Fenway and San Francisco Store Openings
May 17, 2021 | businesswire.com

MedMen Cancels Sale Of 98M Shares On Heels Of Two Cash Positive Quarters
April 26, 2021 | benzinga.com

MedMen Opens Emeryville Location in California
April 8, 2021 | ca.finance.yahoo.com

MedMen CEO Says 'Future Has Never Been Brighter' On Heels Of $16M Private Placement Deal
March 19, 2021 | benzinga.com

MedMen’s New York Subsidiary To Obtain $73 Million Investment From Ascend Wellness Holdings
February 26, 2021 | benzinga.com

Ascend Wellness To Invest In MedMen New York
February 26, 2021 | benzinga.com

MedMen Cancels Co-Founder’s Super-Voting Shares; Stock Down 76% YTD
December 25, 2020 | nasdaq.com

CNSX:MMEN (MedMen Enterprises)
December 3, 2020 | fool.ca

Buds & Duds: MedMen Enterprises trending down on co-founder departures, Green Growth up 4%
June 26, 2020 | www.proactiveinvestors.com

MedMen Announces Changes to Its Board of Directors and Resolution of MMMG-MC Litigation - Designated News Release
June 17, 2020 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange CNSX
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolCNSX:MMEN
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.medmen.com
Phone424-341-4969
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.64 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Medmen Enterprises.

3.2 Community Rank

Outperform Votes
Medmen Enterprises has received 34 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Medmen Enterprises has received 19 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Medmen Enterprises has received 64.15% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Medmen Enterprises and other stocks. Vote “Outperform” if you believe MMEN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MMEN will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Medmen Enterprises does not currently pay a dividend.
Dividend Growth
Medmen Enterprises does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Medmen Enterprises insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Medmen Enterprises (CNSX:MMEN) Frequently Asked Questions

What stocks does MarketBeat like better than Medmen Enterprises?

Wall Street analysts have given Medmen Enterprises a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Medmen Enterprises wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Medmen Enterprises' key executives?

Medmen Enterprises' management team includes the following people:

Mr. Adam Bierman, Co-Founder, CEO & Director (Age 38)
Mr. Andrew Modlin, Co-Founder, Pres & Director (Age 32)
Mr. Michael W. Kramer, Chief Financial Officer (Age 55)
Mr. James Miller, VP of Accounting (Age 59)
Mr. Ryan Lissack, Chief Technology Officer

Who are some of Medmen Enterprises' key competitors?

Some companies that are related to Medmen Enterprises include (THCX.V) (THCX), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Althea Group (AGH), Applied Biosciences (APPB), AusCann Group (AC8), Ayr Strategies (AYRSF), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), Can B (CANB), Cannara Biotech (LOVE), CannPal Animal Therapeutics (CP1), Cansortium (CNTMF) and Chalice Brands (GLDFF).
View all of MMEN's competitors.

What other stocks do shareholders of Medmen Enterprises own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medmen Enterprises investors own include MedMen Enterprises (MMNFF), Aurora Cannabis (ACB), Aurora Cannabis (ACB), The Green Organic Dutchman (TGOD), (CGC), CannTrust (CTST), OrganiGram (OGI), OrganiGram (OGI), Canopy Growth (WEED) and (HEXO).

What is Medmen Enterprises' stock symbol?

Medmen Enterprises trades on the CNSX under the ticker symbol "MMEN."

How do I buy shares of Medmen Enterprises?

Shares of MMEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How many employees does Medmen Enterprises have?

Medmen Enterprises employs 1,000 workers across the globe.

What is Medmen Enterprises' official website?

The official website for Medmen Enterprises is www.medmen.com.

How can I contact Medmen Enterprises?

The company can be reached via phone at 424-341-4969.

This page was last updated on 6/15/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.